Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial-Reference-Cited by-同舟云学术

Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial

Published:2020-12-23 Issue:6 Volume:76 Page:1789-1799
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Ohsawa Isao¹²,Honda Daisuke³,Suzuki Yusuke²,Fukuda Tomoo⁴,Kohga Keisuke⁵,Morita Eishin⁶,Moriwaki Shinichi⁷,Ishikawa Osamu⁸,Sasaki Yoshihiro⁹¹⁰,Tago Masaki¹¹,Chittick Greg¹²,Cornpropst Melanie¹²,Murray Sharon C.¹²,Dobo Sylvia M.¹²,Nagy Eniko¹²,Van Dyke Sharon¹²,Reese Lacy¹²,Best Jessica M.¹²,Iocca Heather¹²,Collis Phil¹²,Sheridan William P.¹²^ORCID,Hide Michihiro¹³^ORCID

Affiliation:

1. Internal Medicine Saiyu Soka Hospital Saitama Japan

2. Division of Nephrology Department of Internal Medicine Juntendo University Faculty of Medicine Tokyo Japan

3. Juntendo University Urayasu Hospital Chiba Japan

4. Saitama Medical Center Saitama Japan

5. Community Hospital Kohga Hospital Shizuoka Japan

6. Shimane University Hospital Shimane Japan

7. Osaka Medical College Hospital Osaka Japan

8. Gunma University Hospital Gunma Japan

9. National Hospital Organization Disaster Medical Center Tokyo Japan

10. Division of Biochemistry Department of Biomedical Sciences Nihon University School of Medicine Tokyo Japan

11. Department of General Medicine Saga University Hospital Saga Japan